Back

Rate versus rhythm control in patients with atrial fibrillation and normal to mild left atrial enlargement: insights from the AFFIRM trial

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Atrial fibrillation - Epidemiology Antiarrhythmic Drug Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor James McCaffrey

George Washington University School of Medicine and Health Sciences, Washington, DC (United States of America)

9 More presentations in this session

Presentation thumbnail
Return to work and maintenance of work after first time hospitalization for atrial fibrillation or flutter
Miss L. Hagengaard (Aalborg, DK)
Abstract
Presentation thumbnail
Long-term relationship between atrial fibrillation and charlson comorbidity index in a population-based cohort study
Associate Professor M. Proietti (Milan, IT)
Abstract Slides
Presentation thumbnail
The impact of hypertension on stroke and mortality in patients with atrial fibrillation: the loire valley atrial fibrillation project
Doctor A. Shantsila (Liverpool, GB)
Abstract
Presentation thumbnail
Comparison of effectiveness, safety, and healthcare costs of direct oral anticoagulants with warfarin in nonvalvular atrial fibrillation patients with heart failure
Miss A. Bassalobre Garcia (Morrisville, US)
Abstract Slides
Presentation thumbnail
Prognostic impact of paroxysmal versus sustained atrial fibrillation on the incidence of cardiac death and heart failure hospitalization:The Fushimi AF Registry
Doctor Y. An (Kyoto, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Atrial fibrillation - Epidemiology

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources